Training Program In The Neurobiology Of Cognition And Cognitive Disorders
认知和认知障碍神经生物学培训计划
基本信息
- 批准号:9302835
- 负责人:
- 金额:$ 18.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This is a competitive renewal application for the Training Program in Neurobiology of Cognition and Cognitive Disorders at the University of Alabama at Birmingham (C&CD Program). Since the C&CD Program was implemented in 2007 under the leadership of Dr. David Sweatt, UAB has made an impressive investment in neuroscience with the areas of cognition and cognitive disorders now being identified as a focal point for strategic development across the entire institution. The C&CD Program is housed in the Department of Neurobiology, and includes 47 faculty from 11 basic science and clinical departments in the School of Medicine (SoM), School of Optometry, and College of Arts and Sciences. The goal of the C&CD Program is to develop the next generation of leaders and scholars in neuroscience research who: have a foundation in molecular, cellular, and cognitive neuroscience theories and research findings; value the importance of using findings from basic science to understanding the basis of cognitive disorders; are prepared to use innovative research approaches to understand cognition and brain-behavior relationships; and will be able to translate this knowledge to treatments and cures of cognitive disorders in the future. The success of the C&CD Program in its first funding period is evidenced by its robust participation (35 total students-18 trainees funded), graduation of a talented cadre of doctoral students (ten total graduates-six funded), with an average of more than four publications each, and all transitioning to competitive postdoctoral positions or completing clinical training. This renewal builds on the successful components of the Program Plan by providing: (1) A curriculum with courses in cellular, molecular, cognitive and translational neuroscience; (2) Clinical shadowing in the "Clinical Evaluation of Cognitive Disorders" course; (3) An outstanding seminar series; (4) Dissertation research with both a basic science and clinical mentor, using experimental approaches that address questions with direct relevance to cognition and cognitive disorders; and (5) Opportunities to hone presentation skills at retreats and national meetings, and instruction in ethical conduct of research, and career development. The specific "value added" components of the C&CD Program include the special clinical/translational training experience in patient-oriented research, interactions with both basic science and clinician scientist mentors,
and distinct extracurricular activities. As the UAB SoM Strategic Plan highlighted cognition and cognitive diseases as an area for major investment with 15 new faculty and $20 million over the next five years, the future of the C&CD Program is secure and it will benefit substantially from this investment with the addition of dynamic new faculty mentors and research facilities.
描述(由申请人提供):这是阿拉巴马大学伯明翰分校认知和认知障碍神经生物学培训项目(C&CD 项目)的竞争性更新申请。自 2007 年在 David Sweatt 博士的领导下实施 C&CD 项目以来,阿拉巴马大学在神经科学领域进行了大量投资,认知和认知障碍领域现已被确定为整个机构战略发展的焦点。 C&CD 项目设在神经生物学系,由来自医学院 (SoM)、视光学院、文理学院 11 个基础科学和临床系的 47 名教职人员组成。 C&CD 计划的目标是培养下一代神经科学研究的领导者和学者,他们: 具有分子、细胞和认知神经科学理论和研究成果的基础;重视利用基础科学发现来理解认知障碍的基础的重要性;准备使用创新的研究方法来理解认知和大脑行为关系;并将能够在未来将这些知识转化为认知障碍的治疗和治愈。 C&CD 项目在第一个资助期的成功体现在其积极参与(总共 35 名学生,资助 18 名实习生),培养了一批优秀的博士生骨干(总共 10 名毕业生,资助 6 名),平均超过每份出版物四份,并且全部过渡到有竞争力的博士后职位或完成临床培训。此次更新以计划计划的成功组成部分为基础,提供了: (1) 包含细胞、分子、认知和转化神经科学课程的课程; (2)《认知障碍的临床评估》课程中的临床观摩; (3) 优秀的系列研讨会; (4) 在基础科学和临床导师的指导下进行论文研究,采用实验方法解决与认知和认知障碍直接相关的问题; (5) 在务虚会和全国会议上磨练演讲技巧的机会,以及研究道德行为和职业发展方面的指导。 C&CD 计划的具体“增值”组成部分包括以患者为导向的研究中的特殊临床/转化培训经验、与基础科学和临床科学家导师的互动、
以及独特的课外活动。由于 UAB SoM 战略计划强调认知和认知疾病是一个重大投资领域,未来五年将新增 15 名教员并投入 2000 万美元,因此 C&CD 项目的未来是有保障的,它将从这项投资中受益匪浅,并增加充满活力的新教师导师和研究设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John J. Hablitz其他文献
John J. Hablitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John J. Hablitz', 18)}}的其他基金
Acquired HCN Channelopathies in Cortical Dysplasia
皮质发育不良中获得性 HCN 通道病
- 批准号:
9091651 - 财政年份:2014
- 资助金额:
$ 18.1万 - 项目类别:
Acquired HCN Channelopathies in Cortical Dysplasia
皮质发育不良中获得性 HCN 通道病
- 批准号:
8808163 - 财政年份:2014
- 资助金额:
$ 18.1万 - 项目类别:
Training Program In The Neurobiology Of Cognition And Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
9104203 - 财政年份:2008
- 资助金额:
$ 18.1万 - 项目类别:
Presynaptic NMDA receptors and GABA release in cortical dysplasia
皮质发育不良中突触前 NMDA 受体和 GABA 释放
- 批准号:
7516663 - 财政年份:2008
- 资助金额:
$ 18.1万 - 项目类别:
Training Program in the Neurobiology of Cognition and Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
10425394 - 财政年份:2008
- 资助金额:
$ 18.1万 - 项目类别:
Training Program in the Neurobiology of Cognition and Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
10197225 - 财政年份:2008
- 资助金额:
$ 18.1万 - 项目类别:
相似国自然基金
基于ImPACT方案的家长干预对孤独症谱系障碍儿童干预疗效及神经生物学机制研究
- 批准号:82301732
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IER3+亚群成纤维细胞样滑膜增生探讨电针调控膝骨关节炎的神经生物学机制
- 批准号:82305367
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FKBP5 SNP rs1360780在甲基苯丙胺使用障碍易感中的作用及神经生物学机制
- 批准号:82373853
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
全氟化合物暴露通过影响脑结构导致情绪精神障碍的神经生物学机制研究
- 批准号:82371924
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
赛洛西宾与氟西汀抗抑郁时效差异的神经生物学机制
- 批准号:32371061
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Characterization of the Neurobiological Profiles of Young Adults with and without Developmental Language Disorder (DLD)
患有和不患有发育性语言障碍 (DLD) 的年轻人的神经生物学特征的表征
- 批准号:
10721464 - 财政年份:2023
- 资助金额:
$ 18.1万 - 项目类别:
Odor memory and functional neuroimaging in cognitively impaired older adults and Alzheimer's disease
认知障碍老年人和阿尔茨海默病的气味记忆和功能神经影像
- 批准号:
10590472 - 财政年份:2023
- 资助金额:
$ 18.1万 - 项目类别:
Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive Decline and AD Risk
主观认知下降和 AD 风险中认知补偿的注意机制
- 批准号:
10738600 - 财政年份:2023
- 资助金额:
$ 18.1万 - 项目类别:
The role of gasdermins in microglial activation and neurodegeneration in ALS/FTD
Gasdermin 在 ALS/FTD 中小胶质细胞激活和神经退行性变中的作用
- 批准号:
10749749 - 财政年份:2023
- 资助金额:
$ 18.1万 - 项目类别:
Endocrine Disruption of the Developing Dopamine System
发育中的多巴胺系统的内分泌干扰
- 批准号:
10601273 - 财政年份:2023
- 资助金额:
$ 18.1万 - 项目类别: